Invacare Corporation  

(Public, NYSE:IVC)   Watch this stock  
Find more results for IVC
17.40
+0.35 (2.05%)
Dec 15 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 17.00 - 17.45
52 week 9.90 - 17.95
Open 17.05
Vol / Avg. 766,555.00/512,991.00
Mkt cap 583.69M
P/E     -
Div/yield 0.01/0.29
EPS -2.34
Shares 32.85M
Beta 2.43
Inst. own 134%
Feb 7, 2018
Q4 2017 Invacare Corp Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 8, 2017
Q3 2017 Invacare Corp Earnings Call - Webcast
Nov 7, 2017
Q3 2017 Invacare Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -7.41% -4.09%
Operating margin -6.03% -2.82%
EBITD margin - -0.51%
Return on average assets -7.19% -4.92%
Return on average equity -17.31% -9.68%
Employees 4,600 -
CDP Score - -

Address

1 Invacare Way PO Box 4028
ELYRIA, OH 44036-2028
United States - Map
+1-440-3296000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company's geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company manufactures and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Company sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services.

Officers and directors

Matthew E. Monaghan Chairman of the Board, President, Chief Executive Officer
Age: 49
Bio & Compensation  - Reuters
Kathleen P. Leneghan Chief Financial Officer, Vice President, Corporate Controller
Age: 54
Bio & Compensation  - Reuters
Anthony C. LaPlaca Senior Vice President, General Counsel, Secretary
Age: 58
Bio & Compensation  - Reuters
Dean J. Childers Senior Vice President, General Manager - North America
Age: 50
Bio & Compensation  - Reuters
Ralf Ledda Senior Vice President, General Manager - Europe, Middle East and Africa
Age: 49
Bio & Compensation  - Reuters
Patricia A. Stumpp Senior Vice President - Human Resources
Age: 55
Bio & Compensation  - Reuters
C. Martin Harris M.D. Lead Independent Director
Age: 60
Bio & Compensation  - Reuters
Barbara W. Bodem Director
Age: 49
Bio & Compensation  - Reuters
Susan H. Alexander Esq. Independent Director
Age: 60
Bio & Compensation  - Reuters
Marc M Gibeley Independent Director
Age: 52
Bio & Compensation  - Reuters